Daniel Bulut
Impact in
-
- Cardiovascular Disease and Adiposity
- Antiplatelet Therapy and Cardiovascular Diseases
- Viral Infections and Immunology Research
- Biochemistry top 10%
- Eicosanoids and Hypertension Pharmacology
Papers in
-
- Cell death mechanisms and regulation 6
- Angiogenesis and VEGF in Cancer 3
-
- Cardiomyopathy and Myosin Studies 2
- Co-authors
- Andreas Mügge (15 shared papers)Christoph Hanefeld (9 shared papers)Jan Börgel (6 shared papers)Vanessa Becker (1 shared paper)Jörg T. Epplen (2 shared papers)Waldemar Uhl (8 shared papers)Ansgar M. Chromik (8 shared papers)Martin Spiecker (3 shared papers)
In The Last Decade
Daniel Bulut
26 papers receiving 668 citations
Peers
Comparison fields: 5 of 103
- Cardiology and Cardiovascular Medicine 208
- Biochemistry 60
- Cancer Research 92
- Internal Medicine 22
- Endocrinology, Diabetes and Metabolism 90
Countries citing papers authored by Daniel Bulut
This map shows the geographic impact of Daniel Bulut's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Bulut with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Bulut more than expected).
Fields of papers citing papers by Daniel Bulut
This network shows the impact of papers produced by Daniel Bulut. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Bulut. The network helps show where Daniel Bulut may publish in the future.
Co-authors
The 25 scholars most cited alongside Daniel Bulut, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 27 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2007 | 71 | |
| 2 | 2011 | 62 | |
| 3 | 2003 | 56 | |
| 4 | 2008 | 54 | |
| 5 | 2008 | 37 | |
| 6 | 2007 | 34 | |
| 7 | 2005 | 33 | |
| 8 | 2008 | 32 | |
| 9 | 2007 | 32 | |
| 10 | 2010 | 31 | |
| 11 | 2009 | 27 | |
| 12 | 2010 | 26 | |
| 13 | 2008 | 26 | |
| 14 | 2011 | 24 | |
| 15 | 2010 | 23 | |
| 16 | 2007 | 16 | |
| 17 | 2012 | 16 | |
| 18 | 2013 | 14 | |
| 19 | 2019 | 13 | |
| 20 | 2010 | 10 |
About Daniel Bulut
Daniel Bulut is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine, Oncology, Endocrinology, Diabetes and Metabolism and Pulmonary and Respiratory Medicine, having authored 27 papers that have together received 682 indexed citations. Recurring topics across this work include Cell death mechanisms and regulation (6 papers), Inflammatory Biomarkers in Disease Prognosis (4 papers), Angiogenesis and VEGF in Cancer (3 papers), NF-κB Signaling Pathways (3 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (2 papers), Alcohol Consumption and Health Effects (2 papers), Cardiomyopathy and Myosin Studies (2 papers) and Hormonal Regulation and Hypertension (2 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (208 citations), Biochemistry (60 citations), Cancer Research (92 citations), Internal Medicine (22 citations) and Endocrinology, Diabetes and Metabolism (90 citations). Daniel Bulut has collaborated with scholars based in Germany and Türkiye. Frequent co-authors include Andreas Mügge, Christoph Hanefeld, Jan Börgel, Vanessa Becker, Jörg T. Epplen, Waldemar Uhl, Ansgar M. Chromik, Martin Spiecker, H. Neubauer and Karin Maier. Their work appears in journals such as Clinical Research in Cardiology, International Journal of Oncology, Journal of Experimental & Clinical Cancer Research, European Journal of Clinical Investigation and Journal of Hypertension.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.